Xilio Therapeutics XLO
NASDAQ XLO
$8.54 +0.00 (+0.00%)
As of: Oct 21, 2026 · 12:37 PM EDT

Xilio Therapeutics (XLO) Operating Expenses (2020 - 2026)

Updated

Xilio Therapeutics (XLO) recorded Operating Expenses of $22.18 million in Q2 2026, down 1.2% from $22.45 million a year earlier and down 17.1% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Operating Expenses (2020 - 2026) Analysis & Trends

On a TTM basis, Xilio Therapeutics' Operating Expenses came in at $95.46 million as of Jun 30, 2026, up 33.3% year-over-year; for FY2025, it came in at $85.75 million, up 28.1% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $66.93 million in FY2024 (-15.4%), $79.13 million in FY2023 (-11.2%), $89.15 million in FY2022 (+18.8%) and $75.04 million in FY2021 (+37.5%).
  • Quarterly Operating Expenses has ranged from $15.35 million in Q4 2024 to $26.76 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Operating Expenses rose in four of the last eight quarters, with growth averaging 19.8%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 66.2% in Q4 2025, against a decline of 25.7% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $26.76 million (Q1 2026), $25.52 million (Q4 2025) and $21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 10.12 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn 10.56 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 9.70 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn 18.20 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 6.68 Bn
10 Xilio Therapeutics 165.72 Mn -361.95 Mn - 22.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.18 Mn
Mar 31, 2026 26.76 Mn
Dec 31, 2025 25.52 Mn
Sep 30, 2025 21.00 Mn
Jun 30, 2025 22.45 Mn
Mar 31, 2025 16.78 Mn
Dec 31, 2024 15.35 Mn
Sep 30, 2024 17.03 Mn
Jun 30, 2024 17.06 Mn
Mar 31, 2024 17.49 Mn
Dec 31, 2023 18.13 Mn
Sep 30, 2023 17.36 Mn
Jun 30, 2023 20.12 Mn
Mar 31, 2023 23.53 Mn
Dec 31, 2022 23.17 Mn
Sep 30, 2022 20.21 Mn
Jun 30, 2022 24.55 Mn
Mar 31, 2022 21.22 Mn
Dec 31, 2021 19.56 Mn
Sep 30, 2021 15.96 Mn
API Access

Xilio Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=XLO&period=max&api_key=YOUR_API_KEY